In summary, this study demonstrated that AnxA1 alleviated ALI in experimental mice by modulating inflammation and oxidative stress through regulating the NLRP3/NF‐κB and Nrf2/HO‐1 signaling pathways. Here, NLRP3 is linked to acute respiratory distress syndrome.